Stay updated on Maplirpacept in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.

Latest updates to the Maplirpacept in Hematologic Malignancies Clinical Trial page
- Check4 days agoChange DetectedThe history shows a new Revision: v3.3.2 added and the previous Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedA new revision entry v3.3.1 was added to the record history, and the revision v3.2.0 was removed. This reflects updates to the study's recorded version history.SummaryDifference0.1%

- Check18 days agoChange DetectedRemoved the notice about government funding and operating status, an administrative banner that described potential delays and NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRecord history shows multiple updates to core content, including study status, contacts/locations, and study description, across numerous versions. The latest version indicates termination of the study by Pfizer with no safety concerns reported.SummaryDifference0.1%

- Check61 days agoChange DetectedUpdated operating status notice and a new software version (v3.2.0) replacing the old v3.1.0.SummaryDifference9%

- Check68 days agoChange DetectedUpdate: Revision from v3.0.2 to v3.1.0. This is a versioning change with no other substantive content alterations.SummaryDifference0.2%

Stay in the know with updates to Maplirpacept in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.